Remission and Joint Damage Progression in Early Rheumatoid Arthritis
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This is a world wide study to evaluate the remission and joint damage in subjects treated
with abatacept in addition to methotrexate versus subjects who receive methotrexate along
with a placebo.